Search Results
Results 1-10 of 3000 items
|
|
Abrams, T. J., Murray, L. J., Pesenti, E., Holway, V. W., Colombo, T., Lee, L. B., Cherrington, J. M., and Pryer, N. K.
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
Molecular Cancer Therapy, 2[10]. 2003.
|
|
|
Abrams, T. J., Murray, L. J., Pesenti, E., Holway, V. W., Colombo, T., Lee, L. B., Cherrington, J. M., and Pryer, N. K.
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
Molecular Cancer Therapy, 2[10]. 2003.
|
|
|
Abrams, T. J., Murray, L. J., Pesenti, E., Holway, V. W., Colombo, T., Lee, L. B., Cherrington, J. M., and Pryer, N. K.
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
Molecular Cancer Therapy, 2[10]. 2003.
|
